Beijing Hotgen Biotech Co., Ltd. (688068.SS) — Stock Score Summary

Beijing Hotgen Biotech Co., Ltd. (688068.SS) has a MoatMap StockRank of 16/100 based on Quality (44/100), Value (40/100), and Momentum (17/100) factor scores. The current signal is STRONG SELL. Beijing Hotgen Biotech is an in-vitro diagnostics company whose pandemic-era demand has completely normalized, leaving it with low momentum and weak growth prospects.

Beijing Hotgen Biotech Co., Ltd. develops in vitro diagnostic (IVD) reagents and instruments, specializing in point-of-care testing (POCT) and chemiluminescence. The company has built a strong domestic and international distribution network, bolstered by rapid regulatory approvals for infectious disease and cardiac marker assays. It is an agile IVD manufacturer with a broad product portfolio spanning immunochromatography and molecular diagnostics.

Key Financial Metrics

Price$11.80
Market Cap$1.2B
Price/Book2.96
Return on Equity-10.7%
Return on Invested Capital-8.8%
Debt/Equity0.15
Gross Margin57.8%
Operating Margin-71.2%
Revenue Growth24.4%
Free Cash Flow$-4M

Beijing Hotgen Biotech Co., Ltd. operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Beijing Hotgen Biotech Co., Ltd.’s (688068.SS) StockRank?
MoatMap’s StockRank for Beijing Hotgen Biotech Co., Ltd. (688068.SS) is 16/100, with a Strong Sell signal. It is a composite of Quality (44), Value (40), and Momentum (17) factor ranks across MoatMap’s 19,000+ stock universe.
Does Beijing Hotgen Biotech Co., Ltd. have an economic moat?
Beijing Hotgen Biotech Co., Ltd. (688068.SS) has a Quality factor score of 44/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Beijing Hotgen Biotech Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Beijing Hotgen Biotech Co., Ltd. (688068.SS) is Strong Sell, based on a StockRank of 16/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Beijing Hotgen Biotech Co., Ltd. in?
Beijing Hotgen Biotech Co., Ltd. (688068.SS) operates in the Healthcare sector, specifically the Biotechnology industry (China).
Browse all ranked stocks688068.SS deep dive reportAI ChampionsHow we score stocksSense-check another stock